262 related articles for article (PubMed ID: 11836178)
1. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
2. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
3. Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
Redei I; Mangan KF; Ming PL; Mullaney MT; Rao PN; Goldberg SL; Klumpp TR
Bone Marrow Transplant; 1997 Mar; 19(5):521-3. PubMed ID: 9052924
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma.
Galli M; Nicolucci A; Valentini M; Belfiglio M; Delaini F; Crippa C; Barbui AM; Giussani U; Rambaldi A; Barbui T
Haematologica; 2005 Dec; 90(12):1643-9. PubMed ID: 16330437
[TBL] [Abstract][Full Text] [Related]
5. [Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
Paule B; Quillard J; Bisson M; Massias P
Nouv Rev Fr Hematol (1978); 1987; 29(6):391-6. PubMed ID: 2454453
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma associated with CD4+ large granular lymphocytic leukemia: a possible causal relationship.
Haran MZ; Basous L; Berrebi A
Hematol J; 2004; 5(5):458-60. PubMed ID: 15448678
[No Abstract] [Full Text] [Related]
7. [Myeloma with extramedullary extension coinciding with the normalization of serum paraproteins after treatment].
Bernat S; Gozalbo T; García-Boyero R; Guinot M
Sangre (Barc); 1998 Feb; 43(1):96-7. PubMed ID: 9577192
[No Abstract] [Full Text] [Related]
8. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
[TBL] [Abstract][Full Text] [Related]
9. Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Yang X; Yang C; Shao K; Ye X; Meng H; Zhou Y; Qian W
Ann Hematol; 2007 Dec; 86(12):919-21. PubMed ID: 17641891
[No Abstract] [Full Text] [Related]
10. Is double autologous stem-cell transplantation appropriate for new multiple myeloma patients?
van Rhee F
Nat Clin Pract Oncol; 2008 Feb; 5(2):70-1. PubMed ID: 17984985
[No Abstract] [Full Text] [Related]
11. [Pneumonia caused by Salmonella in a patient with myeloma].
Fernández P; Roldán V; García MC; Gil MT; Rivas C
Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
[No Abstract] [Full Text] [Related]
12. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
13. [Recent progress in the treatment of hematological malignancies. V. Therapy of multiple myeloma].
Imamura Y
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):809-13. PubMed ID: 2677178
[No Abstract] [Full Text] [Related]
14. Occurrence of multiple myeloma 13 years after Hodgkin's disease: chance or consequence?
Strobel ES; Bauchmüller K; Schmitt-Gräff A; Engelhardt M
Ann Hematol; 2005 Nov; 84(12):830-2. PubMed ID: 16132908
[No Abstract] [Full Text] [Related]
15. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
16. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT.
Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR
Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
[No Abstract] [Full Text] [Related]
19. [p170 in multiple myeloma and acute leukemia].
Riccardi A; Invernizzi R; Ucci G; Luoni R; Danova M; Giordano M; Zambelli ML; Rastaldi MP; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():177-80. PubMed ID: 1684345
[No Abstract] [Full Text] [Related]
20. Bulbar palsy in multiple myeloma.
Chim CS; Ooi GC
Haematologica; 2005 Dec; 90(12 Suppl):ECR42. PubMed ID: 16464757
[No Abstract] [Full Text] [Related]
[Next] [New Search]